 | • レポートコード：QFJ1-4214 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ファブリー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法（ERT）、シャペロン治療、基質減少療法（SRT）、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ファブリー病治療の市場動向 ・企業の競争状況、市場シェア ・ファブリー病治療の種類別市場規模と予測2016-2027（酵素補充療法（ERT）、シャペロン治療、基質減少療法（SRT）、その他） ・ファブリー病治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・ファブリー病治療の北米市場規模2016-2027（アメリカ、カナダ） ・ファブリー病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ファブリー病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ファブリー病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・ファブリー病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi S.A.、Takeda、Amicus Therapeutics Inc.、ISU Abxis Co Ltd.、JCR Pharmaceuticals Co Ltd.、Protalix Biotherapeutics Inc.、Idorsia Pharmaceuticals Ltd.、Avrobio Inc.、Greenovation Biotech GmbH、Moderna Therapeutics Inc.、Green Cross Pharma Pte Ltd.） ・結論 |
Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ dysfunction. This disease is caused by abnormal buildup of a specific fatty matter called globotriaosylceramide in multiple tissues of the body including eyes, skin, kidney, gastrointestinal system, brain, heart, and central nervous system.
Market Analysis and Insights: Global Fabry Disease Treatment Market
The global Fabry Disease Treatment market size is projected to reach US$ 2288.3 million by 2027, from US$ 1532.2 million in 2020, at a CAGR of 5.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fabry Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fabry Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fabry Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fabry Disease Treatment market.
Global Fabry Disease Treatment Scope and Market Size
Fabry Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fabry Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Enzyme Replacement Therapy (ERT)
Chaperone Treatment
Substrate Reduction Therapy (SRT)
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sanofi S.A.
Takeda
Amicus Therapeutics Inc.
ISU Abxis Co Ltd.
JCR Pharmaceuticals Co Ltd.
Protalix Biotherapeutics Inc.
Idorsia Pharmaceuticals Ltd.
Avrobio Inc.
Greenovation Biotech GmbH
Moderna Therapeutics Inc.
Green Cross Pharma Pte Ltd.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fabry Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Enzyme Replacement Therapy (ERT)
1.2.3 Chaperone Treatment
1.2.4 Substrate Reduction Therapy (SRT)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Fabry Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fabry Disease Treatment Market Perspective (2016-2027)
2.2 Fabry Disease Treatment Growth Trends by Regions
2.2.1 Fabry Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Fabry Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Fabry Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Fabry Disease Treatment Industry Dynamic
2.3.1 Fabry Disease Treatment Market Trends
2.3.2 Fabry Disease Treatment Market Drivers
2.3.3 Fabry Disease Treatment Market Challenges
2.3.4 Fabry Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fabry Disease Treatment Players by Revenue
3.1.1 Global Top Fabry Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Fabry Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Fabry Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fabry Disease Treatment Revenue
3.4 Global Fabry Disease Treatment Market Concentration Ratio
3.4.1 Global Fabry Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fabry Disease Treatment Revenue in 2020
3.5 Fabry Disease Treatment Key Players Head office and Area Served
3.6 Key Players Fabry Disease Treatment Product Solution and Service
3.7 Date of Enter into Fabry Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fabry Disease Treatment Breakdown Data by Type
4.1 Global Fabry Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Fabry Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Fabry Disease Treatment Breakdown Data by Application
5.1 Global Fabry Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Fabry Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Fabry Disease Treatment Market Size (2016-2027)
6.2 North America Fabry Disease Treatment Market Size by Type
6.2.1 North America Fabry Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Fabry Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Fabry Disease Treatment Market Size by Type (2016-2027)
6.3 North America Fabry Disease Treatment Market Size by Application
6.3.1 North America Fabry Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Fabry Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Fabry Disease Treatment Market Size by Application (2016-2027)
6.4 North America Fabry Disease Treatment Market Size by Country
6.4.1 North America Fabry Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Fabry Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Fabry Disease Treatment Market Size (2016-2027)
7.2 Europe Fabry Disease Treatment Market Size by Type
7.2.1 Europe Fabry Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Fabry Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Fabry Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Fabry Disease Treatment Market Size by Application
7.3.1 Europe Fabry Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Fabry Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Fabry Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Fabry Disease Treatment Market Size by Country
7.4.1 Europe Fabry Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Fabry Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Fabry Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Fabry Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Fabry Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Fabry Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Fabry Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Fabry Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Fabry Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Fabry Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Fabry Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Fabry Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Fabry Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Fabry Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fabry Disease Treatment Market Size (2016-2027)
9.2 Latin America Fabry Disease Treatment Market Size by Type
9.2.1 Latin America Fabry Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Fabry Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Fabry Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Fabry Disease Treatment Market Size by Application
9.3.1 Latin America Fabry Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Fabry Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Fabry Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Fabry Disease Treatment Market Size by Country
9.4.1 Latin America Fabry Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Fabry Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fabry Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Fabry Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Fabry Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Fabry Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Fabry Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Fabry Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Fabry Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Fabry Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Fabry Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Fabry Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Fabry Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Fabry Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Company Details
11.1.2 Sanofi S.A. Business Overview
11.1.3 Sanofi S.A. Fabry Disease Treatment Introduction
11.1.4 Sanofi S.A. Revenue in Fabry Disease Treatment Business (2016-2021)
11.1.5 Sanofi S.A. Recent Development
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Fabry Disease Treatment Introduction
11.2.4 Takeda Revenue in Fabry Disease Treatment Business (2016-2021)
11.2.5 Takeda Recent Development
11.3 Amicus Therapeutics Inc.
11.3.1 Amicus Therapeutics Inc. Company Details
11.3.2 Amicus Therapeutics Inc. Business Overview
11.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Introduction
11.3.4 Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2016-2021)
11.3.5 Amicus Therapeutics Inc. Recent Development
11.4 ISU Abxis Co Ltd.
11.4.1 ISU Abxis Co Ltd. Company Details
11.4.2 ISU Abxis Co Ltd. Business Overview
11.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Introduction
11.4.4 ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2016-2021)
11.4.5 ISU Abxis Co Ltd. Recent Development
11.5 JCR Pharmaceuticals Co Ltd.
11.5.1 JCR Pharmaceuticals Co Ltd. Company Details
11.5.2 JCR Pharmaceuticals Co Ltd. Business Overview
11.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Introduction
11.5.4 JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2016-2021)
11.5.5 JCR Pharmaceuticals Co Ltd. Recent Development
11.6 Protalix Biotherapeutics Inc.
11.6.1 Protalix Biotherapeutics Inc. Company Details
11.6.2 Protalix Biotherapeutics Inc. Business Overview
11.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Introduction
11.6.4 Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2016-2021)
11.6.5 Protalix Biotherapeutics Inc. Recent Development
11.7 Idorsia Pharmaceuticals Ltd.
11.7.1 Idorsia Pharmaceuticals Ltd. Company Details
11.7.2 Idorsia Pharmaceuticals Ltd. Business Overview
11.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Introduction
11.7.4 Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2016-2021)
11.7.5 Idorsia Pharmaceuticals Ltd. Recent Development
11.8 Avrobio Inc.
11.8.1 Avrobio Inc. Company Details
11.8.2 Avrobio Inc. Business Overview
11.8.3 Avrobio Inc. Fabry Disease Treatment Introduction
11.8.4 Avrobio Inc. Revenue in Fabry Disease Treatment Business (2016-2021)
11.8.5 Avrobio Inc. Recent Development
11.9 Greenovation Biotech GmbH
11.9.1 Greenovation Biotech GmbH Company Details
11.9.2 Greenovation Biotech GmbH Business Overview
11.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Introduction
11.9.4 Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2016-2021)
11.9.5 Greenovation Biotech GmbH Recent Development
11.10 Moderna Therapeutics Inc.
11.10.1 Moderna Therapeutics Inc. Company Details
11.10.2 Moderna Therapeutics Inc. Business Overview
11.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Introduction
11.10.4 Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2016-2021)
11.10.5 Moderna Therapeutics Inc. Recent Development
11.11 Green Cross Pharma Pte Ltd.
11.11.1 Green Cross Pharma Pte Ltd. Company Details
11.11.2 Green Cross Pharma Pte Ltd. Business Overview
11.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Introduction
11.11.4 Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2016-2021)
11.11.5 Green Cross Pharma Pte Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Fabry Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Enzyme Replacement Therapy (ERT)
Table 3. Key Players of Chaperone Treatment
Table 4. Key Players of Substrate Reduction Therapy (SRT)
Table 5. Key Players of Others
Table 6. Global Fabry Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Fabry Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Fabry Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Fabry Disease Treatment Market Share by Regions (2016-2021)
Table 10. Global Fabry Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Fabry Disease Treatment Market Share by Regions (2022-2027)
Table 12. Fabry Disease Treatment Market Trends
Table 13. Fabry Disease Treatment Market Drivers
Table 14. Fabry Disease Treatment Market Challenges
Table 15. Fabry Disease Treatment Market Restraints
Table 16. Global Fabry Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Fabry Disease Treatment Market Share by Players (2016-2021)
Table 18. Global Top Fabry Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fabry Disease Treatment as of 2020)
Table 19. Ranking of Global Top Fabry Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Fabry Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Fabry Disease Treatment Product Solution and Service
Table 23. Date of Enter into Fabry Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Fabry Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Fabry Disease Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Fabry Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Fabry Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Fabry Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Fabry Disease Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Fabry Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Fabry Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Fabry Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Fabry Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Fabry Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Fabry Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Fabry Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Fabry Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Fabry Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Fabry Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Fabry Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Fabry Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Fabry Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Fabry Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Fabry Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Fabry Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Fabry Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Fabry Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Fabry Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Fabry Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Fabry Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Fabry Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Fabry Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Fabry Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Fabry Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Fabry Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Fabry Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Fabry Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Fabry Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Fabry Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Fabry Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Fabry Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Sanofi S.A. Company Details
Table 64. Sanofi S.A. Business Overview
Table 65. Sanofi S.A. Fabry Disease Treatment Product
Table 66. Sanofi S.A. Revenue in Fabry Disease Treatment Business (2016-2021) & (US$ Million)
Table 67. Sanofi S.A. Recent Development
Table 68. Takeda Company Details
Table 69. Takeda Business Overview
Table 70. Takeda Fabry Disease Treatment Product
Table 71. Takeda Revenue in Fabry Disease Treatment Business (2016-2021) & (US$ Million)
Table 72. Takeda Recent Development
Table 73. Amicus Therapeutics Inc. Company Details
Table 74. Amicus Therapeutics Inc. Business Overview
Table 75. Amicus Therapeutics Inc. Fabry Disease Treatment Product
Table 76. Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2016-2021) & (US$ Million)
Table 77. Amicus Therapeutics Inc. Recent Development
Table 78. ISU Abxis Co Ltd. Company Details
Table 79. ISU Abxis Co Ltd. Business Overview
Table 80. ISU Abxis Co Ltd. Fabry Disease Treatment Product
Table 81. ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2016-2021) & (US$ Million)
Table 82. ISU Abxis Co Ltd. Recent Development
Table 83. JCR Pharmaceuticals Co Ltd. Company Details
Table 84. JCR Pharmaceuticals Co Ltd. Business Overview
Table 85. JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Product
Table 86. JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2016-2021) & (US$ Million)
Table 87. JCR Pharmaceuticals Co Ltd. Recent Development
Table 88. Protalix Biotherapeutics Inc. Company Details
Table 89. Protalix Biotherapeutics Inc. Business Overview
Table 90. Protalix Biotherapeutics Inc. Fabry Disease Treatment Product
Table 91. Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2016-2021) & (US$ Million)
Table 92. Protalix Biotherapeutics Inc. Recent Development
Table 93. Idorsia Pharmaceuticals Ltd. Company Details
Table 94. Idorsia Pharmaceuticals Ltd. Business Overview
Table 95. Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Product
Table 96. Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2016-2021) & (US$ Million)
Table 97. Idorsia Pharmaceuticals Ltd. Recent Development
Table 98. Avrobio Inc. Company Details
Table 99. Avrobio Inc. Business Overview
Table 100. Avrobio Inc. Revenue in Fabry Disease Treatment Business (2016-2021) & (US$ Million)
Table 101. Avrobio Inc. Recent Development
Table 102. Greenovation Biotech GmbH Company Details
Table 103. Greenovation Biotech GmbH Business Overview
Table 104. Greenovation Biotech GmbH Fabry Disease Treatment Product
Table 105. Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2016-2021) & (US$ Million)
Table 106. Greenovation Biotech GmbH Recent Development
Table 107. Moderna Therapeutics Inc. Company Details
Table 108. Moderna Therapeutics Inc. Business Overview
Table 109. Moderna Therapeutics Inc. Fabry Disease Treatment Product
Table 110. Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2016-2021) & (US$ Million)
Table 111. Moderna Therapeutics Inc. Recent Development
Table 112. Green Cross Pharma Pte Ltd. Company Details
Table 113. Green Cross Pharma Pte Ltd. Business Overview
Table 114. Green Cross Pharma Pte Ltd. Fabry Disease Treatment Product
Table 115. Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2016-2021) & (US$ Million)
Table 116. Green Cross Pharma Pte Ltd. Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fabry Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Enzyme Replacement Therapy (ERT) Features
Figure 3. Chaperone Treatment Features
Figure 4. Substrate Reduction Therapy (SRT) Features
Figure 5. Others Features
Figure 6. Global Fabry Disease Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Fabry Disease Treatment Report Years Considered
Figure 11. Global Fabry Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Fabry Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Fabry Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Fabry Disease Treatment Market Share by Regions (2022-2027)
Figure 15. Global Fabry Disease Treatment Market Share by Players in 2020
Figure 16. Global Top Fabry Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fabry Disease Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Fabry Disease Treatment Revenue in 2020
Figure 18. Global Fabry Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Fabry Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Fabry Disease Treatment Market Share by Type (2016-2027)
Figure 22. North America Fabry Disease Treatment Market Share by Application (2016-2027)
Figure 23. North America Fabry Disease Treatment Market Share by Country (2016-2027)
Figure 24. United States Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Fabry Disease Treatment Market Share by Type (2016-2027)
Figure 28. Europe Fabry Disease Treatment Market Share by Application (2016-2027)
Figure 29. Europe Fabry Disease Treatment Market Share by Country (2016-2027)
Figure 30. Germany Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Fabry Disease Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Fabry Disease Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Fabry Disease Treatment Market Share by Region (2016-2027)
Figure 40. China Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Fabry Disease Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Fabry Disease Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Fabry Disease Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Fabry Disease Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Fabry Disease Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Fabry Disease Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Fabry Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Sanofi S.A. Revenue Growth Rate in Fabry Disease Treatment Business (2016-2021)
Figure 60. Takeda Revenue Growth Rate in Fabry Disease Treatment Business (2016-2021)
Figure 61. Amicus Therapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2016-2021)
Figure 62. ISU Abxis Co Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2016-2021)
Figure 63. JCR Pharmaceuticals Co Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2016-2021)
Figure 64. Protalix Biotherapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2016-2021)
Figure 65. Idorsia Pharmaceuticals Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2016-2021)
Figure 66. Avrobio Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2016-2021)
Figure 67. Greenovation Biotech GmbH Revenue Growth Rate in Fabry Disease Treatment Business (2016-2021)
Figure 68. Moderna Therapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2016-2021)
Figure 69. Green Cross Pharma Pte Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界のリソソーム蓄積症治療市場規模・現状・予測（2021年-2027年） Lysosomal storage disease (LTD) is caused by defect in lysosomal functions and degradation pathway. It is caused by progressive accumulation of metabolites. LTD is a rare inherited metabolic disorder. Market Analysis and Insights: Global Lysosomal Storage Disease Treatment Market The global Lysosoma…- 世界のライソゾーム病治療市場規模・現状・予測（2021年-2027年） Lysosomal disease treatment is a way to alleviate Lysosomal storage disease. Lysosomal disease is caused by defects in lysosomal function and degradation pathways. It is caused by the gradual accumulation of metabolites. Market Analysis and Insights: Global Lysosomal Disease Treatment Market The glo…
- 世界のペイロニー病治療市場規模・現状・予測（2021年-2027年） Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. Market Analysis and Insights: Global Peyronie’s Disease Treatment Market The global Peyronie’s Disease Treatment market size is projected to reach US$ XX …
- 世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Von Willebrand Disease Treatment Market The global Von Willebrand Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界の転移性骨疾患薬物治療市場規模・現状・予測（2021年-2027年） Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. Market Analysis and Insights: Global Medication Treatment …